Officials launch investigation into Google, Ascension data project

HHS is looking into a secret project between Google and Ascension after news reports revealed Google was collecting personal health information, including names and birthdates, of millions of U.S. patients under the partnership.

Ascension, based in St. Louis, Missouri, is the nation's largest Catholic health system that operates more than 2,600 sites of care across 20 states and the District of Columbia.

The partnership, which was called Project Nightingale, was uncovered by The Wall Street Journal mid-November. The report of the project immediately sparked privacy concerns. Both Ascension and Google executives penned posts to clarify the relationship, asserting Google was not allowed to utilize the data for marketing or research purposes.

However, just a few days after the WSJ broke the story about the project, another major story broke about Google’s forays into the healthcare space. That story, reported by the Washington Post, uncovered Google canceled a public release of 100,000 chest x-ray images after the National Institutes of Health called the tech giant to call off the dump. Some of the images contained identifiable patient information.

The new partnership between Ascension and Google has prompted the HHS Office of Civil Rights to launch an inquiry.

The agency is looking to learn “more information about this mass collection of individuals' medical records with respect to the implications for patient privacy under HIPAA,” Roger Severino, the office’s director, said in a statement.

The project also prompted concern of some politicians, the WSJ reported.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Bridgefield Capital, founded in 2015, has previously invested in such popular brands as Cirque Du Soleil, Del Monte and Quiksilver. This transaction is expected to be completed in the second half of 2025. 

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.